Multiple Assemblies exist for SMTL entry 3h89
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(compound 4); X-RAY DIFFRACTION 2.50 Å

	SMTL ID 3h89.1 Ligands N~2~,N~6~-BIS(BIPHENYL-4-YLACETYL)-L-LYSYL-D-ARGINYL-N-(2-PHENYLETHYL)-L-TYROSINAMIDE Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h89.2 Ligands N~2~,N~6~-BIS(BIPHENYL-4-YLACETYL)-L-LYSYL-D-ARGINYL-N-(2-PHENYLETHYL)-L-TYROSINAMIDE Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h89.3 Ligands N~2~,N~6~-BIS(BIPHENYL-4-YLACETYL)-L-LYSYL-D-ARGINYL-N-(2-PHENYLETHYL)-L-TYROSINAMIDE Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h89.4 Ligands N~2~,N~6~-BIS(BIPHENYL-4-YLACETYL)-L-LYSYL-D-ARGINYL-N-(2-PHENYLETHYL)-L-TYROSINAMIDE Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h89.5 Ligands N~2~,N~6~-BIS(BIPHENYL-4-YLACETYL)-L-LYSYL-D-ARGINYL-N-(2-PHENYLETHYL)-L-TYROSINAMIDE Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h89.6 Ligands N~2~,N~6~-BIS(BIPHENYL-4-YLACETYL)-L-LYSYL-D-ARGINYL-N-(2-PHENYLETHYL)-L-TYROSINAMIDE Polypeptides Cathepsin L1 Oligo-state monomer